Back
CRISPR Therapeutics AG Vs. Vertex Pharmaceuticals Industry Stock Comparison
Buy
66
CRSP
CRISPR Therapeutics AG
Last Price:
56.19
Seasonality Move:
18.28%
Buy
71
VRTX
Vertex Pharmaceuticals
Last Price:
445.29
Seasonality Move:
7.52%
Buy
66
CRISPR Therapeutics AG (CRSP)
is a Buy
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
- The current CRISPR Therapeutics AG [CRSP] share price is $56.22. The Score for CRSP is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- CRSP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $445.21. The Score for VRTX is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- VRTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $56.22
The current trend is relatively stagnant and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $445.21
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.69 | Sell |
| Relative Strength Index (14 RSI): | 47.02 | Sell |
| Chaikin Money Flow: | 885602 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.68 - 56.9) | Buy |
| Bollinger Bands (100): | (56.93 - 76.01) | Sell |
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.17 | Buy |
| Relative Strength Index (14 RSI): | 79.02 | Buy |
| Chaikin Money Flow: | 929485 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (392.72 - 424.92) | Buy |
| Bollinger Bands (100): | (403.76 - 430.1) | Buy |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.78 | Buy |
| 20-day SMA: | 54.94 | Buy |
| 50-day SMA: | 62.33 | Sell |
| 200-day SMA: | 59.32 | Sell |
| 8-day EMA: | 55.47 | Buy |
| 20-day EMA: | 56.17 | Buy |
| 50-day EMA: | 60.58 | Sell |
| 200-day EMA: | 61.45 | Sell |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 430.31 | Buy |
| 20-day SMA: | 412.4 | Buy |
| 50-day SMA: | 409.66 | Buy |
| 200-day SMA: | 388.13 | Buy |
| 8-day EMA: | 430.92 | Buy |
| 20-day EMA: | 418.59 | Buy |
| 50-day EMA: | 412.7 | Buy |
| 200-day EMA: | 390.21 | Buy |
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.56 per share, a decrease next quarter of $0.03 per share, a decrease this year of $2.50 per share, and an increase next year of $1.15 per share.
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.78 per share, an increase this year of $2.05 per share, and an increase next year of $1.12 per share.
CRISPR Therapeutics AG Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vertex Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||